Concepedia
Statistics
Publications
21
Citations
2K
H-Index
17
Active since
1974
Affiliations
University of Washington(Current)
Fred Hutch Cancer Center
Pfizer (United States)
Yale University
Burke Rehabilitation Hospital
Lois M. Hinman is an author at University of Washington specializing in pharmacology, life sciences, and medicine.
Publications per year
1974–2015
Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia
Philip R. Hamann, Lois M. Hinman, Irwin Hollander et al. · Bioconjugate Chemistry · 2001 · 587 citations
Pharmacy, Medicinal Chemistry, Pharmacology +17
Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics.
Lois M. Hinman, Philip R. Hamann, Ryan M. Wallace et al. · PubMed · 1993 · 238 citations
An Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia. Choice of Linker
Philip R. Hamann, Lois M. Hinman, Carl F. Beyer et al. · Bioconjugate Chemistry · 2001 · 227 citations
Medicine, Medicinal Chemistry, Pharmacology +17
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
Oliver W. Press, Darning Shan, J Howell-Clark et al. · PubMed · 1996 · 212 citations
Medicine, Nuclear Medicine, Oncology +13
An NADH-linked spectrophotometric assay for pyruvate dehydrogenase complex in crude tissue homogenates.
Lois M. Hinman, John P. Blass · Journal of Biological Chemistry · 1981 · 139 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +17
1–5 of 21